Nanoscale graphene-based materials (GBMs) enable targeting subcellular structures of the nervous system, a feature crucial for the successful engineering of alternative nanocarriers to deliver drugs and to treat neurodisorders. Among GBMs, graphene oxide (GO) nanoflakes, showing good dispersibility in water solution and being rich of functionalizable oxygen groups, are ideal core structures for carrying biological active molecules to the brain, such as the neuropeptide Y (NPY). In addition, when unconjugated, these nanomaterials have been reported to modulate neuronal function per se. Although some GBM-based nanocarriers have been tested both in vitro and in vivo, a thorough characterization of covalent binding impact on the biological properties of the carried molecule and/or of the nanomaterial is still missing. Here, a copper(I)-catalyzed alkyne–azide cycloaddition strategy was employed to synthesize the GO–NPY complex. By investigating through electrophysiology the impact of these conjugates on the activity of hippocampal neurons, we show that the covalent modification of the nanomaterial, while making GO an inert platform for the vectorized delivery, enhances the duration of NPY pharmacological activity. These findings support the future use of GO for the development of smart platforms for nervous system drug delivery.

Bonding of Neuropeptide Y on Graphene Oxide for Drug Delivery Applications to the Central Nervous System / Cellot, Giada; Jacquemin, Lucas; Reina, Giacomo; FRANCESCHI BIAGIONI, Audrey; Fontanini, Mario; Chaloin, Olivier; Nishina, Yuta; Bianco, Alberto; Ballerini, Laura. - In: ACS APPLIED NANO MATERIALS. - ISSN 2574-0970. - (2022). [10.1021/acsanm.2c03409]

Bonding of Neuropeptide Y on Graphene Oxide for Drug Delivery Applications to the Central Nervous System

Giada Cellot
;
Audrey Franceschi Biagioni;Mario Fontanini;Laura Ballerini
2022-01-01

Abstract

Nanoscale graphene-based materials (GBMs) enable targeting subcellular structures of the nervous system, a feature crucial for the successful engineering of alternative nanocarriers to deliver drugs and to treat neurodisorders. Among GBMs, graphene oxide (GO) nanoflakes, showing good dispersibility in water solution and being rich of functionalizable oxygen groups, are ideal core structures for carrying biological active molecules to the brain, such as the neuropeptide Y (NPY). In addition, when unconjugated, these nanomaterials have been reported to modulate neuronal function per se. Although some GBM-based nanocarriers have been tested both in vitro and in vivo, a thorough characterization of covalent binding impact on the biological properties of the carried molecule and/or of the nanomaterial is still missing. Here, a copper(I)-catalyzed alkyne–azide cycloaddition strategy was employed to synthesize the GO–NPY complex. By investigating through electrophysiology the impact of these conjugates on the activity of hippocampal neurons, we show that the covalent modification of the nanomaterial, while making GO an inert platform for the vectorized delivery, enhances the duration of NPY pharmacological activity. These findings support the future use of GO for the development of smart platforms for nervous system drug delivery.
10.1021/acsanm.2c03409
Cellot, Giada; Jacquemin, Lucas; Reina, Giacomo; FRANCESCHI BIAGIONI, Audrey; Fontanini, Mario; Chaloin, Olivier; Nishina, Yuta; Bianco, Alberto; Ballerini, Laura
File in questo prodotto:
File Dimensione Formato  
2022_ACS Applied NANO Materials.pdf

accesso aperto

Descrizione: pdf editoriale
Tipologia: Versione Editoriale (PDF)
Licenza: Creative commons
Dimensione 5 MB
Formato Adobe PDF
5 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11767/130511
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact